Nu Skin Enterprises (NUS) Misses Q3 EPS by 3c; offers guidance

Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.17, $0.03 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $430.15 million versus the consensus estimate of $440.97 million.

GUIDANCE:

Nu Skin Enterprises sees Q4 2024 EPS of $0.19-$0.29, versus the consensus of $0.28. Nu Skin Enterprises sees Q4 2024 revenue of $410-445 million, versus the consensus of $455.8 million.

Nu Skin Enterprises sees FY2024 EPS of $0.65-$0.75, versus the consensus of $0.77. Nu Skin Enterprises sees FY2024 revenue of $1.7-1.73 billion, versus the consensus of $1.753 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• FDA grants accelerated approval to AstraZeneca's camizestrant combo
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)